News – Page 798 – Endpoints News

Alone in the spotlight, Pfizer CEO Bourla swears pure intentions in the rush to develop a Covid-19 vaccine. But will ...

5 years ago

With a potential FDA approval looming, G1 Therapeutics taps ex-GSK US president Jack Bailey as new CEO

5 years ago

AMAG tops its year-long, activist driven transformation with a $647M selloff to private equity

5 years ago

Is the future of diabetes drugs in dual GIP and GLP-1 incretin receptor agonists? That's the $47M question for Carmot

5 years ago

After recruiting an AstraZeneca vet as CEO to head a new team and raising $139M cash, little Olema appears to be ...

5 years ago

Roche shells out $200M for rights to Vaccibody's neoantigen cancer vaccine

5 years ago

News briefing: Poxel flashes early positive NASH results; Ionis teams up with AI-focused Genuity Science

5 years ago

Mesoblast asks for trading halt as PDUFA date slides by. What's up?

5 years ago

Solid gets another shot in DMD gene therapy race as FDA lifts hold. But is it too late to catch Pfizer, Sarepta?

5 years ago

Bidding to be the go-to genomics and data partner for drug development, Sophia Genetics raises $100M

5 years ago

Covid-19 roundup: EMA starts rolling review of AstraZeneca vaccine; Novavax execs sell millions in stock ahead of ...

5 years ago

A second Carl Icahn protégé jumps in on SPAC spree, as Alex Denner guns for $175M

5 years ago

Its sale to Allergan was called off at the last minute. One year later, a biotech co-founded by Henri Termeer finds a ...

5 years ago

Merck's Roger Perlmutter makes a rare move, joining the board of a machine learning startup out to change the R&D ...

5 years ago

Genfit prunes nearly half its workforce after NASH exit — but CEO promises a future in PBC, diagnostics

5 years ago

The Endpoints 11: Here are some of the most promising startups in biotech. And Covid-19 isn't going to stop them

5 years ago

RNAi trailblazer Alnylam teases more positive data for a potential third commercial drug

5 years ago

A pharma exec gets $100M to chase a cancer-fighting idea uncovered in a 2017 Novartis study

5 years ago

News briefing: Ovid shows mixed results on epilepsy program; Iliad reports positive whooping cough data

5 years ago

BARDA boosts the fight against antibiotic-resistant infections with $144M awards

5 years ago

A new law could open the door to California's own drug pipeline. The state has its sights set on insulin first

5 years ago

Hahn insists FDA will stick to guidelines for Covid-19 vaccine decisions

5 years ago

Jeffrey Bluestone recruits a trio of biopharma vets to the startup team at Sonoma — while adding $30M to the launch ...

5 years ago

District Court throws out Catalyst lawsuit alleging improper approval standards for rival LEMS drug

5 years ago

First page Previous page 795 796 797798799 800 801 Next page Last page